The Latest Coronary Stents Industry Statistics Explained
There were over 7 million procedures carried out globally that involved the implantation of coronary stents, in 2019.
The statistic that there were over 7 million procedures globally involving the implantation of coronary stents in 2019 highlights the widespread use of this medical intervention to treat various cardiovascular conditions. Coronary stents are small, mesh-like tubes that are inserted into narrowed or blocked coronary arteries to improve blood flow to the heart. This statistic suggests that coronary stent implantation is a commonly performed procedure worldwide, indicating both the prevalence of cardiovascular diseases and the effectiveness of stents in managing such conditions. The significant number of procedures underscores the importance of this treatment modality in modern healthcare systems and emphasizes the continuous advancements in medical technology aimed at improving patient outcomes and quality of life.
The global coronary stents market was valued at $8.3 billion in 2020.
The statistic indicates that the total market size of coronary stents worldwide in 2020 was valued at $8.3 billion. This value represents the revenue generated from the sales of coronary stents used in medical procedures to treat blocked arteries. The market size reflects the demand for coronary stents, which are small, mesh-like tubes inserted into narrowed or blocked coronary arteries to help improve blood flow to the heart. The figure of $8.3 billion highlights the significant economic impact and growth potential of the global coronary stents market, driven by factors such as the increasing prevalence of cardiovascular diseases and advancements in medical technology.
The coronary stents market is expected to reach $11.6 billion by 2027.
The statistic that the coronary stents market is expected to reach $11.6 billion by 2027 indicates the projected total value of the market for these medical devices. Coronary stents are small, mesh-like tubes placed in narrowed or blocked coronary arteries to restore blood flow to the heart. The significant growth forecasted in this market suggests a growing demand for coronary stents, likely driven by factors such as an aging population, increasing prevalence of cardiovascular diseases, advancements in technology leading to improved stent designs, and rising awareness about the importance of early intervention in managing heart conditions. This projection highlights the increasing importance of coronary stents in the healthcare industry and the potential economic opportunities for companies operating in this market.
The annual growth rate of the coronary stents market is predicted to be around 5.2% between 2020 and 2027.
The statistic indicates that the coronary stents market is expected to experience an annual growth rate of approximately 5.2% from 2020 to 2027. This implies that the market for coronary stents, which are medical devices used to open blocked arteries and improve blood flow, is projected to expand steadily over this time period. A growth rate of 5.2% suggests that the demand for these devices is increasing, potentially due to factors such as rising cardiovascular disease prevalence, advancements in stent technology, and an aging population. This prediction can be valuable for stakeholders in the healthcare industry to make informed decisions regarding investments, product development, and market strategies related to coronary stents.
The drug-eluting stents segment held the largest share in the coronary stents market in 2019.
This statistic indicates that among all types of coronary stents available in the market in 2019, the drug-eluting stents segment had the highest market share. Drug-eluting stents are a type of coronary stent that releases medication to help prevent the formation of scar tissue and reduce the risk of restenosis, which is the re-narrowing of the arteries. The fact that this segment held the largest share suggests that healthcare providers and patients preferred using drug-eluting stents over other types, such as bare-metal stents or bioresorbable stents, due to their effectiveness in reducing complications and improving patient outcomes. This statistic further highlights the significance of drug-eluting stents in the treatment of coronary artery disease and reflects the trends and preferences in the medical device market in 2019.
North America dominated the market for coronary stents in 2019.
The statistic that ‘North America dominated the market for coronary stents in 2019’ indicates that North America held a significant share of the global market for coronary stents during that year. This means that a large portion of the production, sales, and consumption of coronary stents worldwide occurred in North America. Factors contributing to this dominance could include high levels of healthcare infrastructure and expenditure in the region, a large patient population with cardiovascular diseases, advanced technologies and medical expertise in the field of cardiology, as well as strong market competition. As a result, North America likely played a key role in shaping the trends, innovations, and overall performance of the coronary stent market in 2019.
Bioabsorbable stents are forecasted to grow at the highest Compound Annual Growth Rate (CAGR) of 10.4% between 2020 and 2027.
The statistic indicates that the market for bioabsorbable stents is projected to experience significant growth over the period from 2020 to 2027, with a Compound Annual Growth Rate (CAGR) of 10.4%. This growth rate suggests a robust expansion in the demand for bioabsorbable stents, likely driven by factors such as technological advancements, increasing prevalence of cardiovascular diseases, and a shift towards minimally invasive procedures in healthcare. The forecasted CAGR of 10.4% highlights the potential for substantial market opportunities and indicates that bioabsorbable stents are expected to outpace other stent types in terms of growth rate during the specified time frame.
The bioresorbable stents segment will be the fastest-growing segment in the coronary stent market from 2020 to 2025.
The statement indicates that the bioresorbable stents segment is expected to experience the highest rate of growth among all segments in the coronary stent market between 2020 and 2025. This suggests that there is a significant increase in demand and adoption of bioresorbable stents compared to other types of stents during this period. Factors driving this growth could include advancements in technology, increased awareness among healthcare providers and patients about the benefits of bioresorbable stents, as well as potential regulatory and reimbursement changes favoring these devices. The projected growth rate signifies a shift towards the use of bioresorbable stents in the market and may have implications for both healthcare providers and industry stakeholders operating within the coronary stent market.
Coronary stent procedures in Germany are predicted to increase by 5.4% by 2025.
The statistic that coronary stent procedures in Germany are predicted to increase by 5.4% by 2025 suggests a projected growth in the number of these procedures being performed in the country. This increase is likely due to various factors such as advancements in medical technology, an aging population with a higher prevalence of cardiovascular disease, and increased awareness and access to healthcare services. The prediction signifies a rising demand for coronary stent interventions to treat conditions like coronary artery disease, which can lead to improved outcomes for patients through timely and effective medical interventions. It also highlights the need for healthcare resources to accommodate this anticipated rise in demand for cardiac procedures in Germany.
In 2018, coronary stent procedures made up 79.2% of all American stenting procedures.
In 2018, coronary stent procedures accounted for 79.2% of all stenting procedures performed in the United States. This statistic suggests that the majority of stenting procedures conducted in the country during that year were specifically for coronary arteries. Stents are small mesh tubes used to treat blockages in blood vessels, and coronary stents are specifically designed to keep the arteries that supply blood to the heart open. The high percentage of coronary stent procedures indicates the significance of heart-related issues and the prevalence of coronary artery disease among the American population, highlighting the importance of cardiovascular health in the country.
The use of coronary stents for patients suffering from coronary artery disease (CAD) was 93.6% in 2019.
The statistic indicates that in 2019, 93.6% of patients diagnosed with coronary artery disease (CAD) were treated with coronary stents. Coronary stents are small mesh tubes that are used to treat blockages in the coronary arteries to restore blood flow to the heart. This high percentage suggests that coronary stenting is a commonly utilized and effective treatment option for CAD patients. The widespread use of stents in this context may reflect their established efficacy in improving blood flow, relieving symptoms, and reducing the risk of further complications associated with CAD. Furthermore, the statistic indicates the prevalence of this intervention as a standard practice in managing CAD for a large proportion of patients in 2019.
The mortality rate after one year for coronary artery disease patients treated with stents is around 1.4%.
The statistic stating that the mortality rate after one year for coronary artery disease patients treated with stents is around 1.4% indicates the percentage of patients who pass away within a year following the stent procedure. A low mortality rate of 1.4% suggests that the majority of patients undergoing stent treatment for coronary artery disease survive beyond one year post-procedure. This information provides valuable insights into the effectiveness of stent therapy in managing and potentially improving outcomes for patients with this condition. It is a positive indicator of the success and safety of stent procedures in reducing mortality rates among individuals with coronary artery disease in the short term.
The majority of coronary stents are sold in 5 countries: The United States, China, Germany, France and Japan.
This statistic suggests that the majority of coronary stents are distributed among a select group of countries, namely the United States, China, Germany, France, and Japan. The concentration of sales in these key markets highlights the significance of these countries in the global coronary stent industry. The demand for coronary stents is likely driven by factors such as high incidence of cardiovascular diseases, access to advanced healthcare technologies, and robust healthcare infrastructure in these nations. Understanding the distribution of coronary stent sales can provide insights into the market dynamics, healthcare needs, and technological advancements in these key regions.
Japan has the highest aging population which has driven the demand for coronary stents.
The statistic that Japan has the highest aging population, which has driven the demand for coronary stents, highlights the link between the demographic trend of an aging population and the healthcare services required to address age-related health issues. As people age, the risk of cardiovascular diseases such as coronary artery disease increases, leading to a greater need for medical interventions like coronary stents to improve blood flow to the heart. Given Japan’s rapidly aging population, there is a higher prevalence of cardiovascular conditions, necessitating a corresponding rise in demand for coronary stents to cater to the healthcare needs of this demographic group. This statistic underscores the importance of understanding and addressing the healthcare implications of an aging population and the associated demand for medical devices and treatments to support healthy aging.
More than 100,000 people are treated with coronary stents in the UK each year.
The statistic “More than 100,000 people are treated with coronary stents in the UK each year” means that an annual total of over 100,000 individuals undergo a medical procedure involving the placement of coronary stents in their blood vessels to treat coronary artery disease. This high number illustrates the widespread use and importance of coronary stents as a standard treatment option for this condition in the UK. The statistic highlights both the prevalence of coronary artery disease in the population and the effectiveness of stent procedures in improving the health and quality of life for a significant number of individuals each year.
The introduction of drug-eluting stents has significantly reduced the risk of re-narrowing of the arteries from 30% to 10%.
The statistic indicates that the implementation of drug-eluting stents has led to a substantial decrease in the risk of arteries re-narrowing from 30% to 10%. This implies that the use of drug-eluting stents, as compared to traditional stents, has significantly improved the effectiveness of artery interventions by minimizing the occurrence of re-narrowing after the procedure. Such a reduction is crucial in enhancing the long-term outcomes for patients undergoing stent implantation, as it lowers the likelihood of needing additional interventions or facing complications related to the re-narrowing of the arteries. Overall, this statistic highlights the positive impact of drug-eluting stents on reducing the risk of re-narrowing and improving patient outcomes in the context of arterial interventions.
Conclusion
Overall, the statistics in the Coronary Stents Industry showcase a steady growth and increasing demand for these medical devices. As technology continues to advance, we can expect further innovations in stent design and materials to improve patient outcomes and reduce complications. It is clear that coronary stents play a crucial role in the treatment of cardiovascular disease, and the industry is poised for continued growth in the coming years.
References
0. – https://www.www.alliedmarketresearch.com
1. – https://www.www.statista.com
2. – https://www.www.marketresearchfuture.com
3. – https://www.www.fortunebusinessinsights.com
4. – https://www.www.mordorintelligence.com
5. – https://www.www.bhf.org.uk
6. – https://www.www.ncbi.nlm.nih.gov
7. – https://www.www.marketsandmarkets.com
